Navigation Links
Inclinix Expansion Creates New Position and Promotions
Date:6/3/2008

WILMINGTON, N.C., June 3 /PRNewswire/ -- Inclinix, Inc. a contract research organization that hires physicians and recruits patients for the clinical trials of new drugs, today announced restructuring of positions to support continued growth. Inclinix previously announced a growth rate of 40% in 2007 and the infusion of $10 million in expansion funding, which came in January from Frontier Capital, a private equity firm.

Diane Montross will assume a newly created position, Director of Patient Recruitment. Diane will be responsible for strategically positioning the products and services that support clinical trial enrollment and facilitating customized solutions. Having spent the previous six years with Veritas Medicine as the Director of Media Services, Diane's expertise and industry relationships will be primarily focused toward expanding online patient recruitment and advocacy efforts.

Tobin Geatz, President and Chief Executive Officer of Inclinix, said, "We are delighted that Diane joined the company. She has years of online outreach experience for patients. Now, she will apply her expertise to make our patient outreach programs the best in the industry."

Inclinix's rapid expansion has driven several other internal promotions:

Steve Agnoff has assumed the role of Senior Vice President of Sales and Marketing. He will closely integrate the sales and marketing efforts to drive corporate expansion.

Susan Jalbert has assumed the role of Vice President of Sales. Ms. Jalbert provides strategic direction for a team of business development personnel covering the U.S. and abroad.

Bill Gwinn has assumed the role of Vice President of New Product Development. Gwinn has already led development of new tools named Critical Population Research (CPR(R)). CPR supports feasibility studies, selection of the best trial sites, and optimization of advertising to recruit patients.

Overall employment is growing with increasing sales. Inclinix will maintain its headquarters in Wilmington, NC, but will expand to larger facilities this summer.

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's enrollment CRO. Its IQM(TM) enrollment process uses technology to identify, qualify, and manage patients for the clinical trials of new medical therapies. Clients include pharmaceutical, biotechnology and medical-device organizations. In addition, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com .


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
5. Genzyme Begins Major Expansion of Boston Manufacturing Facility
6. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office
7. AQUISS Continues Expansion Into New Territory
8. Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
9. SAFC Hitech(TM) Plans Further Expansion Into Asia
10. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
11. Mathew to Lead PPD Drug Development Operations and Expansion in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... used in spinal surgical procedures, today announced the completion of a significant transaction ... for current and future customers and partners. Kohlberg & Company, L.L.C. (“Kohlberg”), ...
(Date:4/29/2016)... , April 29, 2016 ... by Transparency Market Research "Separation Systems for Commercial ... Growth, Trends, and Forecast 2015 - 2023", the ... at US$ 10,665.5 Mn in 2014 and is ... from 2015 to 2023 to reach US$ 19,227.8 ...
(Date:4/29/2016)... ... 29, 2016 , ... During a two day program for ... company, CereScan’s CEO, John Kelley, joined other Denver business leaders in providing business ... the Denver area business community, shared his top fundamental learnings in building an ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Summit ... (NSCF) to support the development of a patient-specific stem cell therapy for the treatment ... the lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
Breaking Biology News(10 mins):